CMO, VP Clinical Development, or Head of Operations? How to Choose the Right Leadership Hire for Your Pivotal Moment
You’re at an inflection point. Maybe you’ve just closed a Series B and your lead asset is ready for the clinic. Or perhaps you’re mid-Phase II, realizing your clinical operations infrastructure isn’t scaling the way it needs to. Or you’re a Board member watching timelines stretch and budgets balloon, wondering if the right leadership is in place.
These are pivotal moments… and they demand precision in how you staff your leadership team.
One of the most common questions we hear from biotech and pharma executives is deceptively simple: Which clinical leadership role do we actually need right now? Chief Medical Officer, VP of Clinical Development, Head of Clinical Operations: these titles sound similar, and in smaller organizations, responsibilities often blur. But getting this hire wrong can mean the difference between hitting your Phase II endpoints on time or burning through runway while you course-correct.
We’ve placed leaders across all three roles, and we’ve seen what happens when companies hire the right profile at the right time… and when they don’t. This isn’t about hierarchy or prestige. It’s about matching the specific capabilities of a role to the exact challenge your organization is facing today.
Let’s break it down.
Understanding What Each Role Actually Does
Before we talk strategy, let’s get clear on what differentiates these three positions: because the distinctions matter more than most leadership teams realize.
The Chief Medical Officer is your company’s medical authority and clinical strategist. Typically a licensed physician, the CMO is responsible for medical oversight, clinical governance, and ensuring your programs meet regulatory and ethical standards. They set protocol strategy, lead medical advisory boards, make critical decisions about endpoints and patient populations, and represent the company’s medical perspective to regulators, investors, and the scientific community. The CMO is the person who can defend your clinical rationale in an FDA meeting or pivot your trial design when safety signals emerge.
The VP of Clinical Development serves as the bridge between discovery and the clinic. This role is less about medical credentials (though many have MD or PhD backgrounds) and more about stewarding a program from preclinical stages through early clinical development. The VP of Clinical Development ensures institutional knowledge doesn’t evaporate as your company transitions from research to trials. They maintain continuity, manage cross-functional teams, and often oversee both CMC and clinical timelines in parallel. Think of this as the role that keeps your story intact as you move from mouse models to first-in-human studies.
The Head of Clinical Operations (or VP of Clinical Operations) is your execution engine. This leader operationalizes trials: building site networks, negotiating with CROs, managing vendors, overseeing patient recruitment logistics, and ensuring your studies run on time and on budget. With clinical trials and operations consuming 50% or more of a typical biotech’s budget, this role is fundamentally about efficiency, cost control, and flawless execution. If your CMO decides what to study and why, your Head of Operations ensures it actually happens in the real world.
These aren’t just different job descriptions. They’re different mindsets, skill sets, and value propositions.
When You Need a Chief Medical Officer
You need a CMO when medical credibility and strategic authority are your company’s most pressing gaps.
This typically happens when you’re preparing to enter the clinic for the first time, advancing into pivotal trials, or navigating complex regulatory pathways where medical judgment is paramount. If your Board is asking, “Who’s going to lead the regulatory strategy meeting?” or “Who can we put in front of KOLs to build confidence in our approach?”: you need a CMO.
A strong CMO brings gravitas. They’ve run trials before, they understand what regulators will challenge, and they can make real-time decisions about dose escalation, safety monitoring, and adaptive trial design. They’re the person who can look at emerging data and say, “We need to pause enrollment” or “We’re ready to expand the cohort”: and have the medical authority to back that call.
In our experience, companies hire CMOs too late more often than too early. By the time you’re six months into a Phase I study without clear medical leadership, you’ve already lost time, credibility, andoften, investor confidence. If you’re transitioning from a discovery-stage company to a clinical-stage company, the CMO hire should be one of your first leadership moves.
But here’s the nuance: not every early-stage biotech needs a full-time CMO immediately. Some companies bring in fractional or advisory CMOs to establish medical strategy while they build out operational capabilities. That works… until you hit a moment that demands a full-time medical leader in the room every day.
When You Need a VP of Clinical Development
You need a VP of Clinical Development when continuity and program stewardship are more valuable than immediate operational scale.
This hire makes the most sense when you’re an early-stage company: still in preclinical or early discovery: and you want to avoid the classic trap: losing your most experienced clinical thinkers because they’re not willing to wait two years for your IND to be ready.
The VP of Clinical Development is the person who can start today, contribute to CMC strategy and regulatory planning, and then seamlessly transition into leading your first clinical programs without a handoff. This role prevents the knowledge loss that happens when companies hire consultants for IND prep, then scramble to find a permanent clinical leader once the trial is live.
It’s also the right hire when your company has multiple programs at different stages and you need someone who can manage the portfolio: ensuring that the lessons learned from your lead asset inform how you approach your second and third programs. The VP of Clinical Development thinks horizontally across your pipeline, not just vertically within one trial.
We see this role work particularly well in companies that value long-term alignment and want clinical leadership embedded in the culture early. It’s a bet on continuity over immediate execution, and when it works, it’s incredibly powerful.
When You Need a Head of Clinical Operations
You need a Head of Operations when execution velocity and cost discipline are your top priorities.
This is the hire for companies that already have clinical strategy defined: your CMO or Chief Development Officer has laid out the roadmap: but now you need someone who can make it happen efficiently. If your trials are starting, your CRO invoices are piling up, and you’re realizing you don’t have anyone internally who can manage site activation timelines or negotiate vendor contracts, it’s time for a Head of Operations.
This leader is a builder. They establish systems, optimize workflows, and ensure that operational bottlenecks don’t derail your timelines. They live in the details: patient screening rates, site performance metrics, CRO deliverables, EDC systems, monitoring visit schedules. While your CMO is thinking about the next indication, your Head of Operations is ensuring the current trial doesn’t go over budget.
Particularly in today’s environment: where capital efficiency matters more than ever: the Head of Operations is a strategic role disguised as a tactical one. A great ops leader can extend your runway by months simply by negotiating better CRO rates or streamlining site selection. That’s real value.
A Framework for Your Decision
So how do you choose? Here’s how we typically guide our clients through this decision:
Ask yourself: What is our pivotal moment really about?
If your pivotal moment is about establishing clinical credibility: preparing for your first IND, entering a new indication, or building relationships with regulators and KOLs: hire a CMO. You need medical authority and strategic vision.
If your pivotal moment is about program continuity: bridging from preclinical to clinical stages without losing momentum or institutional knowledge: hire a VP of Clinical Development. You need stewardship and long-term alignment.
If your pivotal moment is about operational excellence: getting trials up and running efficiently, controlling costs, and executing against aggressive timelines: hire a Head of Operations. You need execution and discipline.
Most biotech companies eventually need all three roles. But the sequencing matters enormously. Hiring a Head of Operations when you don’t yet have clinical strategy defined is a recipe for frustration. Hiring a CMO when your real bottleneck is CRO management is expensive and inefficient.
What This Means for Your Next Search
At Denville Partners, we’re privileged to partner with biotech and pharma leaders at exactly these inflection points. We’ve seen companies transform their trajectories with the right clinical hire… and we’ve helped course-correct when the wrong leader was brought in at the wrong time.
Our role isn’t to tell you which title sounds most impressive. It’s to understand your specific moment, your specific bottleneck, and help you find the leader whose capabilities match what you actually need to accomplish in the next 12 to 18 months.
If you’re facing this decision right now: if you’re a CEO or Board member trying to figure out which clinical leadership role will unlock your next stage of growth: we’d welcome the conversation. Sometimes clarity comes from simply talking through your priorities with someone who’s seen this pattern dozens of times before.
Reach out to us at Denville Partners. We’re here to help you get this decision right.